TSPO and Alzheimer disease: 18 kDa TSPO is a potential tool for studying microglial activation and inflammation in early AD. 18F-fempa is a new type of high affinity ligand, two generation TSPO, with suitable pharmacokinetic properties. 18F-fempa seems to increase the detection of TSPO binding in patients with AD with suitable ligands.